M67.27
Synovial hypertrophy, not elsewhere classified, ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy refers to the abnormal thickening of the synovial membrane, the soft tissue lining the joints, which produces synovial fluid. When this condition occurs in the ankle and foot, it can cause discomfort, swelling, and reduced mobility. The ICD-10 code M67.27 is used to classify cases where synovial hypertrophy affects these specific areas but does not fall under more specific categories. Recognizing the symptoms and understanding potential causes can help in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Repetitive joint injury or trauma Chronic inflammatory conditions such as rheumatoid arthritis Degenerative joint diseases like osteoarthritis Infections affecting the joint Overuse or repetitive stress from physical activity Certain autoimmune disorders
Key Symptoms: Swelling and puffiness around the ankle and foot joints Joint stiffness, especially after periods of rest Pain or tenderness during movement or touch A feeling of warmth over the affected joints Limited range of motion or difficulty moving the foot and ankle Possible clicking or catching sensation in the joint
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a clinical examination by a healthcare professional, who assesses symptoms and physical signs. Imaging tests such as ultrasound or MRI are often used to visualize the thickened synovial tissue and assess the extent of hypertrophy. Sometimes, joint fluid analysis or blood tests may be performed to rule out infectious or inflammatory causes and confirm diagnosis.
Treatment Protocols: Treatment focuses on reducing inflammation, alleviating symptoms, and preserving joint function. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to decrease swelling and pain - Physical therapy to improve joint mobility and strength - Rest and joint immobilization during acute flare-ups - Corticosteroid injections to reduce inflammation - Surgical intervention in severe cases, such as synovectomy, to remove excess synovial tissue - Managing underlying conditions like autoimmune diseases to prevent recurrence A healthcare provider will tailor treatment strategies based on the severity and underlying cause of the hypertrophy.
Clinical Advice & FAQs
Billing Guidance
Is M67.27 a billable ICD-10 code?
Yes, M67.27 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.27?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference